Results

• All
• Video
• Audio
• Images

• Most recent

1–2 of 2 results for XLRP

• 

  Subretinal AGTC-501 Gene Therapy for XLRP: 12-Month Interim Safety & Efficacy Results of the Randomized Controlled Multicenter Phase 2 Skyline Trial

  Rajiv Anand, MD, FRCS, FASRS

  Annual Meeting Talks

  2024

• 

  Phase 1/2 Clinical Trial of Intravitreal 4D-125 AAV Gene Therapy in Patients with Advanced XLRP: Interim Safety & Preliminary Activity

  Cagri G Besirli, MD, PhD, FASRS

  Updates from the Field

  2021